THURSDAY, February 18, 2021 (Healthday News) –COVID-19 is a major risk factor for a serious bout, and a new European study suggests that: 1 out of every 5 hospitalized COVID-19 diabetic patients have 28 days of admission. Die inside.
An American expert was not surprised by that serious discovery.
“Diabetic patients are clearly in a very high-risk category and should be among the first groups of people, “Advised Dr. Mangala Narasimhan, who directs critical care services at Northwell Health in New Hyde Park, NY. She advises people with diabetes to make sure they are in control of them. And avoid any complication of the disease.
Narasimhan, who was involved in the new study, said that such steps “really make a difference in terms of survival from COVID infection”.
The research was led by Bertrand Cariou and diabetologist Sami Hedzad of the University Hospital Nantez in France. In May last year, they released a preliminary finding that 10% of COVID-19 patients with diabetes died within seven days of hospitalization.
The new, updated results are of a large number of patients – close to 2,800 – treated for COVID-19 in 68 hospitals in France. Their average age was 70, about two-thirds were male, and many were. About 40% were also experiencing various forms of complications from their diabetes.
During the 28 days of hospitalization, 21% of patients died, the French team reported in the journal on 17 February Diabetologia.
Of those patients who survived for at least one month, 50% were discharged from the hospital with an average stay of nine days; 12% were still hospitalized on day 28, and 17% were transferred from their first hospital to another facility.
Researchers said that younger age, the use of the drug metformin in routine diabetes therapy, and symptoms persisted long before hospitalization. He was more likely to be discharged from the hospital.
Patients who used to take it regularlyInvestigators said it likely indicated more advanced diabetes – with a 44% higher risk of death than those not taking insulin. Prolonged blood sugar control was not associated with patient outcomes, but higher levels of blood sugar at the time of hospital admission were a stronger predictor of death and less likely to discharge.
Dr. Barbara Keber directs family medicine at Glen Cove Hospital in Glen Cove, NY Reading over the findings she said they show that “diabetes is clearly an important risk factor for both ICU / s.”“Within a month of admission” of hospitalization as well as death.
Keiber said it is “prudent” that people with poorly controlled diabetes are at greater risk, as it creates a “pro-inflammatory state” that is similar to elevated COVID-19.
But Keber also cautioned that mortality rates could improve for COVID-19 patients, including those with diabetes, over the past year.
“This study was done in the first wave of the epidemic, and many of the current treatments and drugs that were tried at an early stage have not been found to be beneficial and other treatments have replaced them,” he said.
For example, “the current use of steroids for treatment may play a role in [improved] Keber stated that the prognosis overall and specifically for patients with diabetes.
More on the American Diabetes Association.
Source: Mangala Narasimhan, DO, Director, Vital Care Services, Northwell Health, New Hyde Park, NY; Barbara Keber, MD, chair, family medicine, Glen Cove Hospital, Glen Cove, NY; Diabetologia, News release, February 17, 2021